Cite
APA Citation
Vincken, W., Aumann, J., Jack, D., Chen, H., Henley, M., & Goyal, P. (n.d.). p232 Once-daily co-administration of glycopyrronium and indacaterol via Breezhaler® device improves lung function and symptoms in patients with COPD versus indacaterol alone: the GLOW6 study. Thorax, 68, A181–A182. http://access.bl.uk/ark:/81055/vdc_100135130620.0x000028